• Group A Streptococcus (Streptococcus pyogenes), Molecular Detection, PCR
  • Vasoactive Intestinal Polypeptide (VIP)
  • DKC1 Gene Mutation Analysis
  • Niemann-Pick disease
  • Glycogen storage disease type II (Pompe disease)
  • Congestive heart failure
  • Benign neoplasm, pancreas
  • Systemic lupus erythematosus (SLE)
  • Congenital hypothyroidism
  • Pernicious anemia
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Signatera™ for Minimal Residual Disease (MRD)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Signatera™ for Minimal Residual Disease (MRD)
Medical Test

Methodology
Access to Signatera™ for Minimal Residual Disease (MRD) is restricted.